(S)-1-Cyclohexylethanamine hydrochloride, 97%, 100mg

Methyl 4-methoxy-2-nitrobenzoate, 95.0%, 10g

3-TERT-BUTYL-1-ETHYL-1H-PYRAZOL-5-AMINE, 95.0%, 250mg

1-(2-Imidazol-1-yl-ethyl)-piperazine, 98.5%, 250mg

2',2,2,3'-Tetramethylpropiophenone, 97.0%, 1g

(S)-1-tert-butyl 5-methyl 2-aminopentanedioate hydrochloride, 95.0%, 5g

Methyl 6-chloropyrazolo[1,5-a]pyridine-3-carboxylate, 97%, 1g

3-chloro-2-methoxy-1,4-dihydropyridin-4-one, 97%, 1g

GC capillary column ROTI®Cap-1 MS, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-[4-(prop-2-yn-1-yloxy)phenyl]ethan-1-ol, 95%, 2.5g

(R)-5-(2-(2,5-Difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine, 97%, 1g

(E)-(4-Methoxystyryl)boronic acid, 98%, 1g

7-BROMO-2-METHYL-1,2-DIHYDROISOQUINOLIN-3(4H)-ONE, 97%, 100mg